Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban for prevention of catheter-related venous thrombosis in breast cancer chemotherapy patients
ChiCTR2000031649Phase 2Completed
- Sponsor
- Beijing Chaoyang Sanhuan Cancer Hospital
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of rivaroxaban in Phlebothrombosis (2 arms), sponsored by Beijing Chaoyang Sanhuan Cancer Hospital. Primary endpoint: Catheter-related venous thrombus. Started Apr 2020; status: completed.
02
Drugs
rivaroxaban
03
Conditions
Phlebothrombosis
Beyond the preview
Go deeper on ChiCTR2000031649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031649.